FDAFDA · Food and drugs·Recall number D-0353-2023
Levothyroxine Sodium Tablets, USP 112 mcg, 90 tablets per bottle, Rx Only, Manufactured by Lloyd Inc., Shenandoah, IA, 51601, Distributed by: Alvogen Inc, Pine Brook, NJ 07058, NDC 47781-654-90.
Published March 8, 2023 · Recall initiated: February 6, 2023
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Sub-Potent Drug: Out of specification for assay at the 24 month interval.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- LEVOTHYROXINE SODIUM
- Manufacturer
- Alvogen, Inc
- Distributor
- Nationwide and Puerto Rico.
- UPC
- 0347781649906
- Lot
- Lot # HE02221, Exp. 05/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.